Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

SELL
$65.68 - $81.01 $1.27 Million - $1.57 Million
-19,327 Reduced 47.02%
21,773 $1.69 Million
Q3 2024

Nov 14, 2024

BUY
$64.0 - $116.06 $2.63 Million - $4.77 Million
41,100 New
41,100 $2.75 Million
Q1 2024

May 13, 2024

BUY
$114.22 - $140.1 $3.28 Million - $4.02 Million
28,678 New
28,678 $3.98 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $22.4B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Lighthouse Investment Partners, LLC Portfolio

Follow Lighthouse Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lighthouse Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lighthouse Investment Partners, LLC with notifications on news.